FDA Approved: POMALYST — Original Application (Celgene Corporation)

View source ↗

Summary

FDA approved POMALYST (pomalidomide) from Celgene as the original application for the treatment of multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalyst (pomalidomide)

Snippet

ORIG AP for POMALYST (POMALIDOMIDE)